The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...

Enterprise Products Partners' resilient business has enabled the company to increase its distribution for 26 consecutive ...

As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...

Dividend stocks have remained a popular choice among investors due to the steady income they provide, becoming even more ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total pay increase, according (PDF) to a securities filing.

IXIFI is a biosimilar to Remicade (infliximab). It was approved by Health Canada in December 2021 for all eligible indications of the reference product.

We’re in a somewhat unusual economic predicament right now. On one hand, inflation remains high (at least compared to the ...

Uncle Sam’s abiding ambivalence about having close ties with corporate America is getting some fresh, albeit unwelcome, clarity. Calling U.S. manufacturing capacity the “arsenal of democracy” in 1940, ...

Four Goldman Sachs stock picks make sense for growth and income investors charting a course for the rest of what could be a ...

Taiwan Semiconductor Manufacturing, Salesforce, Oracle, Exxon Mobil, ServiceNow, D-Wave Quantum, and Pfizer are the seven Manufacturing stocks to watch today, according to MarketBeat’s stock screener ...

Representative Jefferson Shreve (R-Indiana) recently bought shares of Pfizer Inc. (NYSE:PFE). In a filing disclosed on March ...

Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that manufactures, develops, markets and sells biopharmaceutical ...